Gallocyanine
Gallocyanine (NCI8642) is a DKK/LRP interaction inhibitor and Wnt/β-catenin signaling pathway activator. Gallocyanine binds to the YWTD repeat domains of LRP5/6, competitively blocks the interaction between DKK and LRP5/6, with an IC50 of approximately 3 μM for inhibiting DKK1 binding to LRP5, an IC50 of 6.38 μM for inhibiting DKK1 binding to LRP6, and a Ki of 14 μM for inhibiting the DKK2C/LRP6-E3E4 interaction. Gallocyanine reverses the inhibitory effect of DKK1 on WNT3A signaling, with an EC50 of approximately 5 μM. Gallocyanine can be used in studies related to Alzheimer's disease, bone formation and glucose metabolism.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 524-26-5
- 分子式: C15H12N2O5
- 分子量:300.27
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
IC50 & Target
[1]|
LPR6 14 μM (Ki) |
体外実験
Gallocyanine (NCI8642) (1-10 μM) potently reverses DKK1-mediated inhibition of WNT3A-stimulated reporter gene activity in NIH 3T3 cells with an EC50 of ~5 μM[1].
Gallocyanine (0.1-100 μM) inhibits DKK1-AP binding to wild-type LRP5-expressing HEK293 cells with an IC50 of about 3 μM, without affecting binding to Kremen1-expressing cells[1].
Gallocyanine inhibits the binding of DKK2C to recombinant LRP6-E3E4 with an inhibition constant of 14 μM[1].
Gallocyanine (100 μM; 2 h) inhibits DKK1 binding to LRP6 in HEK-293LRP6 cells with an IC50 of 6.38 μM, reducing DKK1 binding to 47.8% at 100 μM[2].
Gallocyanine (10-100 μM; 24 h) is not cytotoxic to SH-SY5Y cells at concentrations up to 100 μM after 24 hours of incubation[2].
Gallocyanine (10 μM; 1 h) inhibits PGJ2-induced Tau phosphorylation at serine 396 in mouse primary cortical neurons, reducing phosphorylation levels to 55% at 10 μM[2].
Gallocyanine (0.1-10 μM; 1 h) dose-dependently inhibits DKK1-induced Tau phosphorylation at serine 396 in SH-SY5Y cells[2].
Gallocyanine (0.1-10 μM; 1 h) dose-dependently activates Wnt/β-catenin signaling in SH-SY5Y cells by increasing pGSK3β and β-catenin levels[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SH-SY5Y
-
Concentration:0.1-10 μM
-
Incubation Time:1 h
-
Result:Dose-dependently decreased DKK1-induced Tau phosphorylation at serine 396 relative to cells treated with DKK1 alone.\nDose-dependently increased levels of pGSK3β and β-catenin relative to cells treated with DKK1 alone.
-
Cell Line:SH-SY5Y
-
Concentration:10-100 μM
-
Incubation Time:24 h
-
Result:Exhibited no detectable toxic effects on SH-SY5Y cells at concentrations up to 100 μM.
体内実験
Gallocyanine (IIIC3; 3.5 or 7.0 mg/kg/day; intraperitoneal injection) exerts no obvious overall effect on whole-body bone mineral density (BMD) in mice, but the BMD of the 3.5 mg/kg/day group increases by approximately 3% at the end of the experiment[1].
Gallocyanine (IIIC3; i.p.) reduces blood glucose levels during routine toxicity monitoring in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD-1 (6 weeks old)[1]
-
Dosage:3.5 mg/kg/d; 7.0 mg/kg/d
-
Administration:s.c.; three times daily; 5 days; i.p.; daily
-
Result:Did not meaningfully alter whole-body BMD; 3.5 mg/kg/day increased BMD by approximately 3% at endpoint.
化学情報
-
CAS 番号 524-26-5
-
分子量 300.27
-
分子式 C15H12N2O5
-
SMILES
O=C(C1=CC(C(O)=C2OC3=C(N=C21)C=CC(N(C)C)=C3)=O)O
-
別名
NCI8642
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
純度とドキュメンテーション
参考文献
[1]. Li X, et al. Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America. 2012 Jul 10;109(28):11402-7. [Content Brief]
[2]. Thysiadis S, et al. Design and Synthesis of Gallocyanine Inhibitors of DKK1/LRP6 Interactions for Treatment of Alzheimer's Disease. Bioorganic Chemistry. 2018 [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Gallocyanine 関連分類
HY-124841 関連分類
Powered by Bioz